produced a decrease in thepercentage of proliferation in the CD3+,CD3+CD4+, and CD3+CD8+ cellsubpopulations of RA patients and healthy controls, at concentrations of 252and 126 μg/mL. The gene discussed is CD8A; the disease is rheumatoid arthritis.